EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study

Yonghoon Shin, Jung-Joon Cha, Ju Hyeon Kim, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Minae Park, Yujin Lee, Soon Jun Hong iD

PLOS One · 11.11.2026 · 21 (11) · e0362218

DOI: 10.1371/journal.pone.0362218 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS One, online erschienen am 11.11.2026. Verfasst von Yonghoon Shin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Colchicine, Diabetes Mellitus, Type 2, Gout, Gout Suppressants. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colchicine has been associated with reduced cardiovascular events in secondary prevention, but evidence for primary prevention is limited. We examined the association between colchicine use and cardiovascular outcomes in patients with type 2 diabetes mellitus and gout without prior coronary artery disease. From the Korean National Health Insurance Service database, we identified 48,295 patients with diabetes and gout without prior coronary artery disease between 2015 and 2019. We compared 28,964 colchicine users with 19,331 non-users by 1:1 propensity score matching, which produced 17,337 matched pairs. The primary outcome was a composite of all-cause death, nonfatal myocardial infarction, and nonfatal stroke. The primary composite outcome occurred in 12.52% of colchicine users versus 15.03% of non-users (hazard ratio [HR] 0.71; 95% confidence interval [CI] 0.66–0.75; P < 0.001). All-cause mortality was significantly reduced in colchicine users (8.01% vs. 11.07%; HR 0.58; 95% CI 0.53–0.62; P < 0.001). No significant differences were observed for myocardial infarction (HR 1.15; 95% CI 0.96–1.37; P = 0.121) or stroke (HR 0.91; 95% CI 0.81–1.01; P = 0.076). In a landmark analysis at 365 days that addressed immortal time bias, the associations with all-cause mortality (HR 0.67; 95% CI 0.62–0.73; P < 0.001) and with the composite outcome (HR 0.76; 95% CI 0.71–0.81; P < 0.001) remained significant, whereas stroke (HR 0.99; 95% CI 0.87–1.12; P = 0.823) and myocardial infarction (HR 1.15; 95% CI 0.95–1.40; P = 0.144) did not differ between the two groups. In patients with diabetes and gout without prior coronary artery disease, colchicine use was associated with lower all-cause mortality. The reduction in the composite outcome was driven by mortality rather than by myocardial infarction or stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineDiabetes Mellitus, Type 2GoutGout SuppressantsHumansMaleFemaleMiddle AgedAgedCoronary Artery DiseaseRepublic of KoreaPropensity ScoreCohort StudiesMyocardial InfarctionStrokeCause of Death

Substanzen

ColchicineGout Suppressants

Autor:innen und Institutionen

  • Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.
  • Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea.

ORCID-Profile: Soon Jun Hong

Zitieren

APA

Shin, Y., Cha, J. J., Kim, J. H., Joo, H. J., Park, J. H., Yu, C. W., Park, M., Lee, Y., & Hong, S. J. (2026). Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study. PLOS One, 21(11), e0362218. https://doi.org/10.1371/journal.pone.0362218

Vancouver

Shin Y, Cha JJ, Kim JH, Joo HJ, Park JH, Yu CW, et al. Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study. PLOS One. 2026;21(11):e0362218. doi:10.1371/journal.pone.0362218

BibTeX
@article{Shin2026,
  author = {Shin, Yonghoon and Cha, Jung-Joon and Kim, Ju Hyeon and Joo, Hyung Joon and Park, Jae Hyoung and Yu, Cheol Woong and Park, Minae and Lee, Yujin and Hong, Soon Jun},
  title = {Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0362218},
  doi = {10.1371/journal.pone.0362218}
}
Kostenlos starten →